Back
Open Access

Direct oral anticoagulants in patients with heart failure and atrial fibrillation: do we have an ideal score to predict major bleeding?

Session: Advances in cardiovascular pharmacotherapy
Topic: Anticoagulants
Speaker: Doctor V. De Simone (Legnago, IT)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Vincenzo De Simone

Mater Salutis Hospital, Legnago (Italy)
3 presentations
0 follower

5 more presentations in this session

Intravenous loop diuretic-induced decongestion in heart failure: an explorative study in a real-world population

Speaker: Mr M. Erhardsson (Stockholm, SE)

Access
Abstract
Like
Thumbnail

Incidence of erythrocytosis and thromboembolic risk in patients with heart failure and reduced ejection fraction treated with SGLT2 Inhibitors

Speaker: Doctor A. Mohamed (Copenhagen, DK)

Access
Abstract
Like
Thumbnail

Efficacy and safety of sotagliflozin in patients with symptomatic obstructive and non-obstructive hypertrophic cardiomyopathy (SONATA-HCM): study design

Speaker: Professor I. Olivotto (Florence, IT)

Access
Abstract
Like
Thumbnail

The impact of early SGLT2i inclusion in quadruple therapy for de novo patients: enhancing medication management and clinical outcomes

Speaker: Doctor A. Esteban Fernandez (Leganes, ES)

Access
Abstract
Like
Thumbnail

Assessing the best anticoagulation strategy for left ventricle thrombus after anterior myocardial infarction

Speaker: Doctor F. Rodrigues Santos (Viseu, PT)

Access
Abstract
Like
Thumbnail

Access the full session

Advances in cardiovascular pharmacotherapy

Speakers: Doctor V. De Simone, Mr M. Erhardsson, Doctor A. Mohamed, Professor I. Olivotto, Doctor A. Esteban Fernandez...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources